Skip to main content

Page of 2 next disabled
and
  1. No Access

    Protocol

    Microarray Technology for Use in Molecular Epidemiology

    Microarrays are a powerful laboratory tool for the simultaneous assessment of the activity of thousands genes. Remarkable advances in biological sample collection, preparation and automation of hybridization h...

    Suzanne D. Vernon, Toni Whistler in Microarrays (2007)

  2. Article

    Open Access

    Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus

    Acute infectious diseases are typically accompanied by non-specific symptoms including fever, malaise, irritability and somnolence that usually resolve on recovery. However, in some individuals these symptoms ...

    Suzanne D Vernon, Toni Whistler, Barbara Cameron, Ian B Hickie in BMC Infectious Diseases (2006)

  3. Article

    Open Access

    Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study

    The lack of standardized criteria for defining chronic fatigue syndrome (CFS) has constrained research. The objective of this study was to apply the 1994 CFS criteria by standardized reproducible criteria.

    William C Reeves, Dieter Wagner, Rosane Nisenbaum, James F Jones in BMC Medicine (2005)

  4. Article

    Open Access

    Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome

    People with chronic fatigue syndrome (CFS) suffer from multiple symptoms including fatigue, impaired memory and concentration, unrefreshing sleep and musculoskeletal pain. The exact causes of CFS are not known...

    Suzanne D Vernon, William C Reeves in Journal of Autoimmune Diseases (2005)

  5. Article

    Open Access

    Gene expression profile of cervical tissue compared to exfoliated cells: Impact on biomarker discovery

    Exfoliated cervical cells are used in cytology-based cancer screening and may also be a source for molecular biomarkers indicative of neoplastic changes in the underlying tissue. However, because of keratiniza...

    Martin Steinau, Daisy R Lee, Mangalathu S Rajeevan, Suzanne D Vernon in BMC Genomics (2005)

  6. Article

    Open Access

    Exercise responsive genes measured in peripheral blood of women with Chronic Fatigue Syndrome and matched control subjects

    Chronic fatigue syndrome (CFS) is defined by debilitating fatigue that is exacerbated by physical or mental exertion. To search for markers of CFS-associated post-exertional fatigue, we measured peripheral blo...

    Toni Whistler, James F Jones, Elizabeth R Unger, Suzanne D Vernon in BMC Physiology (2005)

  7. No Access

    Article

    Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome

    We used differential-display PCR of peripheral blood mononuclear cells (PBMCs) to search for candidate biomarkers for chronic fatigue syndrome (CFS). PBMCs were collected from a subject with CFS and an age- an...

    Martin Steinau, Elizabeth R. Unger, Suzanne D. Vernon in Journal of Molecular Medicine (2004)

  8. Article

    Open Access

    The economic impact of chronic fatigue syndrome

    Chronic fatigue syndrome (CFS) is a chronic incapacitating illness that affects between 400,000 and 800,000 Americans. Despite the disabling nature of this illness, scant research has addressed the economic im...

    Kenneth J Reynolds, Suzanne D Vernon in Cost Effectiveness and Resource Allocation (2004)

  9. No Access

    Protocol

    Molecular Characterization of Human Papillomaviruses by PCR and In Situ Hybridization

    The goal of early detection and screening is the diagnosis and treatment of cancer before it spreads beyond the organ of origin, perhaps even in its preinvasive state. Unfortunately, available early detection ...

    Suzanne D. Vernon, Elizabeth R. Unger in Molecular Diagnosis of Cancer (2004)

  10. Article

    Open Access

    Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution

    Chronic fatigue syndrome (CFS) is defined by symptoms and disability, has no confirmatory physical signs or characteristic laboratory abnormalities, and the etiology and pathophysiology remain unknown. Difficu...

    William C Reeves, Andrew Lloyd, Suzanne D Vernon in BMC Health Services Research (2003)

  11. Article

    Open Access

    Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome

    Chronic fatigue syndrome (CFS) has no diagnostic clinical signs or diagnostic laboratory abnormalities and it is unclear if it represents a single illness. The CFS research case definition recommends stratifyi...

    Toni Whistler, Elizabeth R Unger, Rosane Nisenbaum in Journal of Translational Medicine (2003)

  12. Article

    Open Access

    Bioelectronic DNA detection of human papillomaviruses using eSensor™: a model system for detection of multiple pathogens

    We used human papillomaviruses (HPV) as a model system to evaluate the utility of a nucleic acid, hybridization-based bioelectronic DNA detection platform (eSensor™) in identifying multiple pathogens.

    Suzanne D Vernon, Daniel H Farkas, Elizabeth R Unger in BMC Infectious Diseases (2003)

  13. Article

    Open Access

    Analysis of 16S rRNA gene sequences and circulating cell-free DNA from plasma of chronic fatigue syndrome and non-fatigued subjects

    The association of an infectious agent with chronic fatigue syndrome (CFS) has been difficult and is further complicated by the lack of a known lesion or diseased tissue. Cell-free plasma DNA could serve as a ...

    Suzanne D Vernon, Sanjay K Shukla, Jennifer Conradt, Elizabeth R Unger in BMC Microbiology (2002)

  14. No Access

    Protocol

    Detection of Human Papillomaviruses by Polymerase Chain Reaction and In Situ Hybridization

    The clinical utility of human papillomavirus (HPV) testing continues to be the focus of much debate. The clear epidemiologic link of HPV infection with the development of cervical intraepithelial neoplasia and...

    Elizabeth R. Unger, Suzanne D. Vernon in Molecular Pathology Protocols (2001)

Page of 2 next disabled